Skystar Begins Pre-production Field Trials Of Met-Enk

Skystar has initiated early-stage field experiments of its proprietary – Methionine Enkephalin (Met-Enk) powder.

Met-Enk is designed to boost the immune system of livestock, which helps animals’ immune systems to better resist certain viral diseases, including Porcine Circovirus, Porcine Reproductive and Respiratory Syndrome.

Early studies in pigs and guinea pigs suggest that when Met-Enk is injected, it could prove effective in preventing the onset of swine-related H1N1 and H3N2 viruses, or swine flu, Coronavirus, Influenza A, Herpes, HIV, Cytomegalovirus, Japanese encephalitis and Friend leukemia virus.

Weibing Lu, chairman and CEO at Skystar, said: We are continuing to build our portfolio of products and are on track to meet our goal of introducing 40 new products this year. The addition of Met-Enk marks an important addition to our arsenal of veterinary medications as it could play a significant role in helping to prevent and treat costly viral-based diseases among China’s farm breeding industry.

We’re currently distributing Met-Enk to a select group of our large scale farming customers. Early feedback indicates that our customers have found Met-Enk is particularly useful when given to the animal at birth. When used as a standard precautionary measure it will help maintain the overall health of the livestock and our customers have seen notable declines in abortion, still birth rates and increased weaned pig survival rates. We plan to increase production and roll-out this product to our complete customer base in the coming months, he added.